APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phenylketonuria (PKU)

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

This report mainly focuses on the treatment for PKU.

Selected research

Industry Growth & Trends

Global Phenylketonuria (PKU) Industry Growth and Trends Forecast to 2032

21 December 202599 pages

Choose your research edition.

Industry ResearchPhenylketonuria (PKU) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenylketonuria (PKU) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Phenylketonuria (PKU) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenylketonuria (PKU) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenylketonuria (PKU) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

This report mainly focuses on the treatment for PKU.

In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Phenylketonuria (PKU) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phenylketonuria (PKU) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phenylketonuria (PKU) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toPhenylketonuria (PKU).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phenylketonuria (PKU) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phenylketonuria (PKU) Market by Company

Biomarin

Mead Johnson

Abbott

Nutricia

Dr. Schär

Vitaflo

Cambrooke

PKU Perspectives

Firstplay Dietary

Phenylketonuria (PKU) Segment by Type

Medications

Supplements

Others

Phenylketonuria (PKU) Segment by Application

Household

Hospital

Phenylketonuria (PKU) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenylketonuria (PKU) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenylketonuria (PKU) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenylketonuria (PKU).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phenylketonuria (PKU) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Medications Table 2. Major Company of Supplements Table 3. Major Company of Others Table 4. Global Phenylketonuria (PKU) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Phenylketonuria (PKU) Sales by Type (2021-2026) & (k units) Table 6. Global Phenylketonuria (PKU) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Phenylketonuria (PKU) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Phenylketonuria (PKU) Sales Market Share in Value by Type (2021-2026) Table 9. Global Phenylketonuria (PKU) Price by Type (2021-2026) & (USD/unit) Table 10. Global Phenylketonuria (PKU) Sales by Type (2027-2032) & (k units) Table 11. Global Phenylketonuria (PKU) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Phenylketonuria (PKU) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Phenylketonuria (PKU) Sales Market Share in Value by Type (2027-2032) Table 14. Global Phenylketonuria (PKU) Price by Type (2027-2032) & (USD/unit) Table 15. North America Phenylketonuria (PKU) Sales by Type (2021-2026) & (k units) Table 16. North America Phenylketonuria (PKU) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Phenylketonuria (PKU) Sales by Type (2021-2026) & (k units) Table 18. Europe Phenylketonuria (PKU) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Phenylketonuria (PKU) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Phenylketonuria (PKU) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Phenylketonuria (PKU) Sales by Type (2021-2026) & (k units) Table 22. Latin America Phenylketonuria (PKU) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Phenylketonuria (PKU) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Phenylketonuria (PKU) Sales by Type (2021-2026) & (US$ Million) Table 25. Phenylketonuria (PKU) Industry Trends Table 26. Phenylketonuria (PKU) Industry Drivers Table 27. Phenylketonuria (PKU) Industry Opportunities and Challenges Table 28. Phenylketonuria (PKU) Industry Restraints Table 29. Global Phenylketonuria (PKU) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Phenylketonuria (PKU) Revenue Market Share by Company (2021-2026) Table 31. Global Phenylketonuria (PKU) Sales by Company (2021-2026) & (k units) Table 32. Global Phenylketonuria (PKU) Sales Share by Company (2021-2026) Table 33. Global Phenylketonuria (PKU) Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Phenylketonuria (PKU) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Phenylketonuria (PKU) Major Company Production Sites and Headquarters Table 36. Global Phenylketonuria (PKU) Company, Product Type & Application Table 37. Global Phenylketonuria (PKU) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Phenylketonuria (PKU) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Phenylketonuria (PKU) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Phenylketonuria (PKU) Sales by Region (2021-2026) & (k units) Table 42. Global Phenylketonuria (PKU) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Phenylketonuria (PKU) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Phenylketonuria (PKU) Sales Market Share in Value by Region (2021-2026) Table 45. Global Phenylketonuria (PKU) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Phenylketonuria (PKU) Sales by Region (2027-2032) & (k units) Table 47. Global Phenylketonuria (PKU) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Phenylketonuria (PKU) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Phenylketonuria (PKU) Sales Market Share in Value by Region (2027-2032) Table 50. Global Phenylketonuria (PKU) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Phenylketonuria (PKU) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Phenylketonuria (PKU) Sales by Application (2021-2026) & (k units) Table 53. Global Phenylketonuria (PKU) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Phenylketonuria (PKU) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Phenylketonuria (PKU) Sales Market Share in Value by Application (2021-2026) Table 56. Global Phenylketonuria (PKU) Price by Application (2021-2026) & (USD/unit) Table 57. Global Phenylketonuria (PKU) Sales by Application (2027-2032) & (k units) Table 58. Global Phenylketonuria (PKU) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Phenylketonuria (PKU) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Phenylketonuria (PKU) Sales Market Share in Value by Application (2027-2032) Table 61. Global Phenylketonuria (PKU) Price by Application (2027-2032) & (USD/unit) Table 62. North America Phenylketonuria (PKU) Sales by Application (2021-2026) & (k units) Table 63. North America Phenylketonuria (PKU) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Phenylketonuria (PKU) Sales by Application (2021-2026) & (k units) Table 65. Europe Phenylketonuria (PKU) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Phenylketonuria (PKU) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Phenylketonuria (PKU) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Phenylketonuria (PKU) Sales by Application (2021-2026) & (k units) Table 69. Latin America Phenylketonuria (PKU) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Phenylketonuria (PKU) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Phenylketonuria (PKU) Sales by Application (2021-2026) & (US$ Million) Table 72. Biomarin Company Information Table 73. Biomarin Business Overview Table 74. Biomarin Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Biomarin Phenylketonuria (PKU) Product Portfolio Table 76. Biomarin Recent Development Table 77. Mead Johnson Company Information Table 78. Mead Johnson Business Overview Table 79. Mead Johnson Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Mead Johnson Phenylketonuria (PKU) Product Portfolio Table 81. Mead Johnson Recent Development Table 82. Abbott Company Information Table 83. Abbott Business Overview Table 84. Abbott Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Abbott Phenylketonuria (PKU) Product Portfolio Table 86. Abbott Recent Development Table 87. Nutricia Company Information Table 88. Nutricia Business Overview Table 89. Nutricia Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Nutricia Phenylketonuria (PKU) Product Portfolio Table 91. Nutricia Recent Development Table 92. Dr. Schär Company Information Table 93. Dr. Schär Business Overview Table 94. Dr. Schär Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Dr. Schär Phenylketonuria (PKU) Product Portfolio Table 96. Dr. Schär Recent Development Table 97. Vitaflo Company Information Table 98. Vitaflo Business Overview Table 99. Vitaflo Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Vitaflo Phenylketonuria (PKU) Product Portfolio Table 101. Vitaflo Recent Development Table 102. Cambrooke Company Information Table 103. Cambrooke Business Overview Table 104. Cambrooke Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Cambrooke Phenylketonuria (PKU) Product Portfolio Table 106. Cambrooke Recent Development Table 107. PKU Perspectives Company Information Table 108. PKU Perspectives Business Overview Table 109. PKU Perspectives Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. PKU Perspectives Phenylketonuria (PKU) Product Portfolio Table 111. PKU Perspectives Recent Development Table 112. Firstplay Dietary Company Information Table 113. Firstplay Dietary Business Overview Table 114. Firstplay Dietary Phenylketonuria (PKU) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Firstplay Dietary Phenylketonuria (PKU) Product Portfolio Table 116. Firstplay Dietary Recent Development Table 117. North America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. North America Phenylketonuria (PKU) Sales by Country (2021-2026) & (k units) Table 119. North America Phenylketonuria (PKU) Sales Market Share by Country (2021-2026) Table 120. North America Phenylketonuria (PKU) Sales Forecast by Country (2027-2032) & (k units) Table 121. North America Phenylketonuria (PKU) Sales Market Share Forecast by Country (2027-2032) Table 122. North America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Phenylketonuria (PKU) Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Phenylketonuria (PKU) Market Share by Country (2021-2026) Table 125. North America Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Phenylketonuria (PKU) Market Share Forecast by Country (2027-2032) Table 127. Europe Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Europe Phenylketonuria (PKU) Sales by Country (2021-2026) & (k units) Table 129. Europe Phenylketonuria (PKU) Sales Market Share by Country (2021-2026) Table 130. Europe Phenylketonuria (PKU) Sales Forecast by Country (2027-2032) & (k units) Table 131. Europe Phenylketonuria (PKU) Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Phenylketonuria (PKU) Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Phenylketonuria (PKU) Market Share by Country (2021-2026) Table 135. Europe Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Phenylketonuria (PKU) Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Phenylketonuria (PKU) Sales by Country (2021-2026) & (k units) Table 139. Asia-Pacific Phenylketonuria (PKU) Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Phenylketonuria (PKU) Sales Forecast by Country (2027-2032) & (k units) Table 141. Asia-Pacific Phenylketonuria (PKU) Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Phenylketonuria (PKU) Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Phenylketonuria (PKU) Market Share by Country (2021-2026) Table 145. Asia-Pacific Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Phenylketonuria (PKU) Market Share Forecast by Country (2027-2032) Table 147. Latin America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Latin America Phenylketonuria (PKU) Sales by Country (2021-2026) & (k units) Table 149. Latin America Phenylketonuria (PKU) Sales Market Share by Country (2021-2026) Table 150. Latin America Phenylketonuria (PKU) Sales Forecast by Country (2027-2032) & (k units) Table 151. Latin America Phenylketonuria (PKU) Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Phenylketonuria (PKU) Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Phenylketonuria (PKU) Market Share by Country (2021-2026) Table 155. Latin America Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Phenylketonuria (PKU) Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Phenylketonuria (PKU) Sales by Country (2021-2026) & (k units) Table 159. Middle East and Africa Phenylketonuria (PKU) Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Phenylketonuria (PKU) Sales Forecast by Country (2027-2032) & (k units) Table 161. Middle East and Africa Phenylketonuria (PKU) Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Phenylketonuria (PKU) Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Phenylketonuria (PKU) Market Share by Country (2021-2026) Table 165. Middle East and Africa Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Phenylketonuria (PKU) Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Phenylketonuria (PKU) Distributors List Table 170. Phenylketonuria (PKU) Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Phenylketonuria (PKU) Image Figure 2. Global Phenylketonuria (PKU) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenylketonuria (PKU) Market Size (2021-2032) & (US$ Million) Figure 4. Global Phenylketonuria (PKU) Sales (2021-2032) & (k units) Figure 5. Medications Image Figure 6. Global Medications Sales YoY Growth (2021-2032) & (k units) Figure 7. Supplements Image Figure 8. Global Supplements Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Phenylketonuria (PKU) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Phenylketonuria (PKU) Market Share by Type 2025 VS 2032 Figure 13. North America Phenylketonuria (PKU) Sales Market Share in Volume by Type in 2025 Figure 14. North America Phenylketonuria (PKU) Sales Market Share in Value by Type in 2025 Figure 15. Europe Phenylketonuria (PKU) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Phenylketonuria (PKU) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Phenylketonuria (PKU) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Phenylketonuria (PKU) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Phenylketonuria (PKU) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Phenylketonuria (PKU) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Phenylketonuria (PKU) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Phenylketonuria (PKU) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Phenylketonuria (PKU) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Household Image Figure 26. Global Household Sales YoY Growth (2021-2032) & (k units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Phenylketonuria (PKU) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Phenylketonuria (PKU) Market Share by Application 2025 VS 2032 Figure 31. North America Phenylketonuria (PKU) Sales Market Share in Volume by Application in 2025 Figure 32. North America Phenylketonuria (PKU) Sales Market Share in Value by Application in 2025 Figure 33. Europe Phenylketonuria (PKU) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Phenylketonuria (PKU) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Phenylketonuria (PKU) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Phenylketonuria (PKU) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Phenylketonuria (PKU) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Phenylketonuria (PKU) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Phenylketonuria (PKU) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Phenylketonuria (PKU) Sales Market Share in Value by Application in 2025 Figure 41. North America Phenylketonuria (PKU) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Phenylketonuria (PKU) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Phenylketonuria (PKU) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Phenylketonuria (PKU) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Phenylketonuria (PKU) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Phenylketonuria (PKU) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Phenylketonuria (PKU) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Phenylketonuria (PKU) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Phenylketonuria (PKU) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Phenylketonuria (PKU) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Phenylketonuria (PKU) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Phenylketonuria (PKU) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Phenylketonuria (PKU) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Phenylketonuria (PKU) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Phenylketonuria (PKU) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Phenylketonuria (PKU) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Phenylketonuria (PKU) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Phenylketonuria (PKU) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Phenylketonuria (PKU) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Phenylketonuria (PKU) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Phenylketonuria (PKU) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Phenylketonuria (PKU) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Medications
  • Supplements
  • Others
Applications
  • Household
  • Hospital
Companies covered
  • Biomarin
  • Mead Johnson
  • Abbott
  • Nutricia
  • Dr. Schär
  • Vitaflo
  • Cambrooke
  • PKU Perspectives
  • Firstplay Dietary

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phenylketonuria (PKU) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phenylketonuria (PKU) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phenylketonuria (PKU) Market by Type
  6. 1.3.1 Medications
  7. 1.3.2 Supplements
  8. 1.3.3 Others
  9. 1.4 Global Phenylketonuria (PKU) Market Size by Type
  10. 1.4.1 Global Phenylketonuria (PKU) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Phenylketonuria (PKU) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Phenylketonuria (PKU) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Phenylketonuria (PKU) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Phenylketonuria (PKU) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Phenylketonuria (PKU) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Phenylketonuria (PKU) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Phenylketonuria (PKU) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phenylketonuria (PKU) Industry Trends
  2. 2.2 Phenylketonuria (PKU) Industry Drivers
  3. 2.3 Phenylketonuria (PKU) Industry Opportunities and Challenges
  4. 2.4 Phenylketonuria (PKU) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phenylketonuria (PKU) Revenue (2021-2026)
  2. 3.2 Global Top Players by Phenylketonuria (PKU) Sales (2021-2026)
  3. 3.3 Global Top Players by Phenylketonuria (PKU) Price (2021-2026)
  4. 3.4 Global Phenylketonuria (PKU) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phenylketonuria (PKU) Major Company Production Sites & Headquarters
  6. 3.6 Global Phenylketonuria (PKU) Company, Product Type & Application
  7. 3.7 Global Phenylketonuria (PKU) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phenylketonuria (PKU) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phenylketonuria (PKU) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phenylketonuria (PKU) Tier 1, Tier 2, and Tier 3
4 Phenylketonuria (PKU) Regional Status and Outlook
  1. 4.1 Global Phenylketonuria (PKU) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phenylketonuria (PKU) Historic Market Size by Region
  3. 4.2.1 Global Phenylketonuria (PKU) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phenylketonuria (PKU) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phenylketonuria (PKU) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phenylketonuria (PKU) Forecasted Market Size by Region
  7. 4.3.1 Global Phenylketonuria (PKU) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phenylketonuria (PKU) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phenylketonuria (PKU) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phenylketonuria (PKU) by Application
  1. 5.1 Phenylketonuria (PKU) Market by Application
  2. 5.1.1 Household
  3. 5.1.2 Hospital
  4. 5.2 Global Phenylketonuria (PKU) Market Size by Application
  5. 5.2.1 Global Phenylketonuria (PKU) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Phenylketonuria (PKU) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Phenylketonuria (PKU) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Phenylketonuria (PKU) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Phenylketonuria (PKU) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Phenylketonuria (PKU) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Phenylketonuria (PKU) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Phenylketonuria (PKU) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biomarin
  2. 6.1.1 Biomarin Company Information
  3. 6.1.2 Biomarin Business Overview
  4. 6.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biomarin Phenylketonuria (PKU) Product Portfolio
  6. 6.1.5 Biomarin Recent Developments
  7. 6.2 Mead Johnson
  8. 6.2.1 Mead Johnson Company Information
  9. 6.2.2 Mead Johnson Business Overview
  10. 6.2.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mead Johnson Phenylketonuria (PKU) Product Portfolio
  12. 6.2.5 Mead Johnson Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Abbott Phenylketonuria (PKU) Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Nutricia
  20. 6.4.1 Nutricia Company Information
  21. 6.4.2 Nutricia Business Overview
  22. 6.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nutricia Phenylketonuria (PKU) Product Portfolio
  24. 6.4.5 Nutricia Recent Developments
  25. 6.5 Dr. Schär
  26. 6.5.1 Dr. Schär Company Information
  27. 6.5.2 Dr. Schär Business Overview
  28. 6.5.3 Dr. Schär Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Schär Phenylketonuria (PKU) Product Portfolio
  30. 6.5.5 Dr. Schär Recent Developments
  31. 6.6 Vitaflo
  32. 6.6.1 Vitaflo Company Information
  33. 6.6.2 Vitaflo Business Overview
  34. 6.6.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vitaflo Phenylketonuria (PKU) Product Portfolio
  36. 6.6.5 Vitaflo Recent Developments
  37. 6.7 Cambrooke
  38. 6.7.1 Cambrooke Company Information
  39. 6.7.2 Cambrooke Business Overview
  40. 6.7.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cambrooke Phenylketonuria (PKU) Product Portfolio
  42. 6.7.5 Cambrooke Recent Developments
  43. 6.8 PKU Perspectives
  44. 6.8.1 PKU Perspectives Company Information
  45. 6.8.2 PKU Perspectives Business Overview
  46. 6.8.3 PKU Perspectives Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PKU Perspectives Phenylketonuria (PKU) Product Portfolio
  48. 6.8.5 PKU Perspectives Recent Developments
  49. 6.9 Firstplay Dietary
  50. 6.9.1 Firstplay Dietary Company Information
  51. 6.9.2 Firstplay Dietary Business Overview
  52. 6.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Firstplay Dietary Phenylketonuria (PKU) Product Portfolio
  54. 6.9.5 Firstplay Dietary Recent Developments
7 North America by Country
  1. 7.1 North America Phenylketonuria (PKU) Sales by Country
  2. 7.1.1 North America Phenylketonuria (PKU) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phenylketonuria (PKU) Sales by Country (2021-2026)
  4. 7.1.3 North America Phenylketonuria (PKU) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phenylketonuria (PKU) Market Size by Country
  6. 7.2.1 North America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phenylketonuria (PKU) Market Size by Country (2021-2026)
  8. 7.2.3 North America Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phenylketonuria (PKU) Sales by Country
  2. 8.1.1 Europe Phenylketonuria (PKU) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phenylketonuria (PKU) Sales by Country (2021-2026)
  4. 8.1.3 Europe Phenylketonuria (PKU) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phenylketonuria (PKU) Market Size by Country
  6. 8.2.1 Europe Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phenylketonuria (PKU) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phenylketonuria (PKU) Sales by Country
  2. 9.1.1 Asia-Pacific Phenylketonuria (PKU) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phenylketonuria (PKU) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phenylketonuria (PKU) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phenylketonuria (PKU) Market Size by Country
  6. 9.2.1 Asia-Pacific Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phenylketonuria (PKU) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phenylketonuria (PKU) Sales by Country
  2. 10.1.1 South America Phenylketonuria (PKU) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phenylketonuria (PKU) Sales by Country (2021-2026)
  4. 10.1.3 South America Phenylketonuria (PKU) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phenylketonuria (PKU) Market Size by Country
  6. 10.2.1 South America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phenylketonuria (PKU) Market Size by Country (2021-2026)
  8. 10.2.3 South America Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phenylketonuria (PKU) Sales by Country
  2. 11.1.1 Middle East and Africa Phenylketonuria (PKU) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phenylketonuria (PKU) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phenylketonuria (PKU) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phenylketonuria (PKU) Market Size by Country
  6. 11.2.1 Middle East and Africa Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phenylketonuria (PKU) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phenylketonuria (PKU) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phenylketonuria (PKU) Value Chain Analysis
  2. 12.1.1 Phenylketonuria (PKU) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phenylketonuria (PKU) Production Mode & Process
  7. 12.2 Phenylketonuria (PKU) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phenylketonuria (PKU) Distributors
  10. 12.2.3 Phenylketonuria (PKU) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst